Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-20

Clinical Trial Update: A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101) [Phase 1]

View source ↗

Summary

Phase 1 study CHAPTER-GIST-101 is evaluating pimitespib in combination with imatinib for gastrointestinal stromal tumors; the trial is currently active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imatinib (imatinib)
  • Pimitespib (pimitespib)

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Gastrointestinal Stromal Tumors | Phase 1 | Status: ACTIVE_NOT_RECRUITING